MAPT and supranuclear palsy, progressive, 1: PSP is characterized by the accumulation of hyperphosphorylated tau proteins in both neurons and glial cells, primarily affecting the brainstem, basal ganglia, and cerebellum, leading to a range of motor, cognitive, and oculomotor deficits.7